BioAegis Therapeutics Secures $3,732,412 New Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=1b3158e2-131b-4127-83bc-e4a482691b1a
Date
2/10/2014
Company Name
BioAegis Therapeutics
Mailing Address
Undisclosed Boston, MA 02108
Company Description
BioAegis Therapeutics’ products will restore depleted levels of plasma gelsolin, an integral and ubiquitous, natural human protein, whose important clinical role is now emerging.
Website
http://www.bioaegistherapeutics.com
Transaction Type
Debt
Transaction Amount
$3,732,412
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
M&A Terms
Venture Investor
Undisclosed